Best Buy Co., Inc. (BBY) - 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended August 2, 2025 (Fiscal Q2 2026) and the six months ended August 2, 2025. Best Buy operates two reportable segments: Domestic (U.S. operations and Best Buy Health) and International (Canada). The company is a large accelerated filer with 210.1 million shares of common stock outstanding as of September 3, 2025.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Revenue | $9,438 million | $9,288 million | $18,205 million | $18,135 million |
| Comparable Sales Growth | 1.6% | -2.3% | 0.4% | -4.2% |
| Gross Profit | $2,194 million | $2,186 million | $4,243 million | $4,250 million |
| Gross Margin | 23.2% | 23.5% | 23.3% | 23.4% |
| Operating Income | $251 million | $383 million | $470 million | $695 million |
| Operating Margin | 2.7% | 4.1% | 2.6% | 3.8% |
| Net Earnings | $186 million | $291 million | $388 million | $537 million |
| Diluted EPS | $0.87 | $1.34 | $1.82 | $2.47 |
| Operating Cash Flow (YTD) | $783 million (vs. $817 million YTD 2024) | |||
| Cash & Equivalents | $1,456 million (as of Aug 2, 2025) | |||
| Total Debt | $1,174 million (Long-term: $1,164m; Current: $10m) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 1.6% in Q2 and 0.4% YTD, driven by growth in computing, mobile phones, and gaming, partially offset by declines in home theater and appliances.
- Restructuring Charges: Significant non-recurring charges impacted profitability. Q2 2025 included $114 million in restructuring charges (vs. a $7 million benefit in Q2 2024), and YTD 2025 totaled $223 million (vs. $8 million YTD 2024). These relate to a new "Labor and Store Optimization" initiative and the optimization of the Best Buy Health business.
- Profitability Decline: Operating income and Net Earnings decreased significantly year-over-year due to the aforementioned restructuring charges and lower product margin rates.
- Segment Performance:
- Domestic: Revenue flat YTD; comparable sales up 0.2%. Online sales grew 3.7% YTD.
- International: Revenue up 5.4% YTD; comparable sales up 3.5%, driven by gaming and computing growth in Canada.
- Store Count: Total stores decreased to 1,105 from 1,120 in the prior year, with plans to close select non-traditional locations.
Guidance, Outlook, and Risks
- Restructuring Outlook: Management does not expect to incur material future restructuring charges related to the current Labor and Store Optimization or Best Buy Health initiatives.
- Capital Allocation: The company continues to return capital to shareholders. In the first six months of 2025, it repurchased $167 million of stock and paid $403 million in dividends. Approximately $3.1 billion remains available under the $5.0 billion share repurchase program.
- Tariff Risks: The company faces uncertainty regarding tariffs, noting that 30-35% of products purchased are reliant on vendor imports from China. Management is working with vendors to mitigate impacts.
- Seasonality: A large proportion of revenue and earnings is generated in the fiscal fourth quarter (holiday season); interim results are not indicative of full-year performance.
- Goodwill Impairment: A $475 million goodwill impairment was recorded in fiscal 2025 for the Best Buy Health reporting unit. No further impairment was identified in Q2 2025.
Investor Verification Checklist
- Restructuring Impact: Verify the specific cash outflows associated with the $223 million YTD restructuring charges and the timeline for future payments (accruals of $172 million remain).
- Margin Pressure: Assess the sustainability of gross margin rates (23.3% YTD) given the shift in sales mix toward lower-margin categories and potential tariff impacts.
- Best Buy Health Strategy: Review the details of the "exit of a component" of the Best Buy Health business and its long-term strategic implications.
- Inventory Levels: Monitor merchandise inventories, which increased to $5,816 million (up from $5,085 million at the start of the fiscal year), potentially indicating slower sell-through in certain categories.
- Share Count Reduction: Confirm the effectiveness of share repurchases in offsetting dilution, noting the weighted-average shares outstanding decreased from 216.1 million (YTD 2024) to 211.8 million (YTD 2025).